aztreonam was administered to 30 patients , ages 0.03 to 15.4 years , with severe and in 21 cases complicated urinary tract infections caused by members of the family enterobacteriaceae and pseudomonas aeruginosa which were resistant to ampicillin and susceptible to the study drug in vitro .
C0004521
aztreonam
C0042029
urinary tract infections